Aldo Faisal is Professor of AI & Neuroscience at Imperial College London (since 2009) and Chair in Digital Health at Universität Bayreuth, Germany (since 2022). He holds a UKRI Turing AI Fellowship and directs the £55m UKRI Centres in AI for Health—one of the world’s largest research and training programmes in medical AI. His textbook Mathematics for Machine Learning is an Amazon Global Top 10 in computer science, and he has co-created university and executive AI degrees across three countries to help bridge the global skills gaps.
Internationally recognised as one of the first computer scientists leading clinical trials that translate AI from algorithms to the bedside, Aldo develops solutions unimaginable before AI—such as AI-driven discovery of digital biomarkers that de-risk drug development in rare disease (now commercialised through his spin-out Ethomix Ltd), and the AI Clinician, a breakthrough system for AI-driven intensive care treatments.
Beyond research, he has actively shaped global AI policy and regulation, co-authoring white papers with governments and regulators. His expertise was recognised by the German Parliament, which appointed him as the first computer scientist to the German Ethics Council in 2024.
He now spearheads Nightingale AI, an international effort to build the world’s first health foundation model, trained on millions of donated patient records and powered by Europe’s largest supercomputers.
